Brief: Harvard Bioscience Posts Q4 Adjusted EPS Of $0.08

Harvard Bioscience

26/02/2020 12:46

Feb 26 (Reuters) - Harvard Bioscience Inc  HBIO.O :
    * HARVARD BIOSCIENCE ANNOUNCES FOURTH QUARTER 2019 FINANCIAL
RESULTS
    * Q4 ADJUSTED EARNINGS PER SHARE $0.08
    * Q4 EARNINGS PER SHARE $0.01
    * Q4 REVENUE $31 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$31.8
MILLION
    * Q4 EARNINGS PER SHARE ESTIMATE $0.09 -- REFINITIV IBES
DATA
    * RESTRUCTURING PROGRAM IS EXPECTED TO BE COMPLETED BY END
OF 2020
    * EXPECT LOW SINGLE DIGIT REVENUE GROWTH FOR YEAR
    * EXPECT LOW SINGLE DIGIT REVENUE GROWTH FOR 2020
    * PLAN TO CONTINUE TO PAY DOWN DEBT TO BELOW 3 TIMES
LEVERAGE BY
END OF FIRST HALF OF 2020
    * EXPECTS TO INCUR COSTS ASSOCIATED WITH HEADCOUNT
REDUCTIONS,
OTHERS TOTALING $4 MILLION TO $5 MILLION
    * EXPECT MAJORITY OF RESTRUCTURING ACTIVITIES COMPLETED IN
H1 2020
    * PLAN TO EXPLORE REFINANCING EXISTING DEBT TO A LOWER
INTEREST
RATE

Source text for Eikon:  ID:nGNX8sgfsS 
Further company coverage:  HBIO.O 

 ((Reuters.Briefs@thomsonreuters.com;))